These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 858558)

  • 21. Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic.
    Takeishi M; Mimori A; Nakajima K; Mimura T; Suzuki T
    Clin Rheumatol; 2003 Feb; 22(1):40-4. PubMed ID: 12605317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hageman factor in experimental nephrotoxic nephritis in the rabbit.
    Wiggins RC
    Lab Invest; 1985 Sep; 53(3):335-48. PubMed ID: 3928966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procoagulant and platelet aggregating properties of antilymphocyte sera.
    Kimball DB; Rickles FR; Gockerman JP; Hattler BG; Light JA; Conrad ME
    J Lab Clin Med; 1976 May; 87(5):868-81. PubMed ID: 1270893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.
    Switalska HI; Niewiarowski S; Tuszynski GP; Rucinski B; Schmaier AH; Morinelli TA; Cierniewski CS
    J Lab Clin Med; 1985 Dec; 106(6):690-700. PubMed ID: 2415646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of Hageman factor by cardiac arrest.
    Latour JG; McKay DG; Parrish MH
    Thromb Diath Haemorrh; 1972 Jul; 27(3):543-53. PubMed ID: 4662615
    [No Abstract]   [Full Text] [Related]  

  • 27. Guinea pig Hageman factor as a vascular permeability enhancement factor.
    Yamamoto T; Cochrane CG
    Am J Pathol; 1981 Nov; 105(2):164-75. PubMed ID: 6794374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay of human Hageman factor (factor XII).
    Saito H; Ratnoff OD; Pensky J
    J Lab Clin Med; 1976 Sep; 88(3):506-14. PubMed ID: 956701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of novel monoclonal antibodies against rabbit platelet factor four.
    Cazzola F; Saggin L; Callegaro L
    Hybridoma; 1992 Feb; 11(1):61-9. PubMed ID: 1737641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural changes accompanying enzymatic activation of human Hageman factor.
    Revak SD; Cochrane CG; Johnston AR; Hugli TE
    J Clin Invest; 1974 Sep; 54(3):619-27. PubMed ID: 4277669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstituted collagen is not capable of activating factor XII but causes intrinsic coagulation by activating platelets.
    Kawamoto Y; Kaibara M
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):371-9. PubMed ID: 1330022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of factor VIII-free plasma by immunoaffinity chromatography on insolubilized antibodies against factor VIII-related antigen.
    Tran TH; Duckert F
    Haemostasis; 1983; 13(2):73-7. PubMed ID: 6409711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electroimmunoassay of factor XII antigen increased sensitivity by silver staining of immunoprecipitate--factor XII antigen in cases from 9 Japanese families with congenital factor XII deficiency].
    Takamiya O; Funahashi S; Kinoshita S; Yoshioka K; Sakata M; Yoshikawa I; Yoshioka A
    Rinsho Byori; 1987 Nov; 35(11):1282-6. PubMed ID: 2451044
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified factor XII has a higher specific activity than the parent molecule in plasma.
    Wuillemin WA; Furlan M; Huber I; Lämmle B
    Thromb Haemost; 1991 Feb; 65(2):169-73. PubMed ID: 2053104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody neutralization in hypoprothrombinaemic plasma.
    Parkin JD; Madaras F; Castaldi PA
    Haemostasis; 1972-1973; 1(5):253-60. PubMed ID: 4677582
    [No Abstract]   [Full Text] [Related]  

  • 37. Hageman factor activity in liquoid-induced consumption coagulopathy. Failure to prevent the drop in Hageman factor activity by anticoagulation with a coumarin derivative.
    Müller-Berghaus G; Lasch HG
    Thromb Diath Haemorrh; 1971 Aug; 26(1):58-70. PubMed ID: 5112377
    [No Abstract]   [Full Text] [Related]  

  • 38. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
    Kornecki E; Tuszynski GP; Niewiarowski S
    Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.